Literature DB >> 16775724

Growth hormone deficiency in a patient with lysinuric protein intolerance.

Valentina Esposito1, Teresa Lettiero, Simona Fecarotta, Gianfranco Sebastio, Giancarlo Parenti, Mariacarolina Salerno.   

Abstract

INTRODUCTION: Lysinuric protein intolerance (LPI; MIM 222700) is a rare, autosomal recessive metabolic disorder caused by mutations in the SLC7A7 gene, which encodes the light chain of the cationic amino acids (CAA) transporter y+. The clinical presentation of LPI includes gastrointestinal symptoms, failure to thrive, episodes of coma, hepatosplenomegaly and osteoporosis. However, other findings have also been reported, and these suggest a multisystem involvement. DISCUSSION: We report a girl with confirmed LPI who presented with severe short stature that was unresponsive to adequate LPI treatment. The girl was found to have a classic growth hormone deficiency (GHD) and responded well to growth hormone (GH) replacement therapy.
CONCLUSION: While it is not known whether the mechanisms involved in the GHD of our patient are related to LPI, this case suggests that GH/IGF-I axis should be investigated in LPI children with persistent growth failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775724     DOI: 10.1007/s00431-006-0170-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee.

Authors:  Thomas A Wilson; Susan R Rose; Pinchas Cohen; Alan D Rogol; Philippe Backeljauw; Rosalind Brown; Dana S Hardin; Stephen F Kemp; Margaret Lawson; Sally Radovick; Stephen M Rosenthal; Lawrence Silverman; Phyllis Speiser
Journal:  J Pediatr       Date:  2003-10       Impact factor: 4.406

2.  PLASMA GROWTH HORMONE RESPONSE TO INTRAVENOUS ADMINISTRATION OF AMINO ACIDS.

Authors:  R F KNOPF; J W CONN; S S FAJANS; J C FLOYD; E M GUNTSCHE; J A RULL
Journal:  J Clin Endocrinol Metab       Date:  1965-08       Impact factor: 5.958

3.  Recurrent fatal pulmonary alveolar proteinosis after heart-lung transplantation in a child with lysinuric protein intolerance.

Authors:  Francesca Santamaria; Gianluca Brancaccio; Giancarlo Parenti; Paola Francalanci; Cosimo Squitieri; Gianfranco Sebastio; Carlo Dionisi-Vici; Patrizia D'argenio; Generoso Andria; Francesco Parisi
Journal:  J Pediatr       Date:  2004-08       Impact factor: 4.406

4.  Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.

Authors:  D Torrents; J Mykkänen; M Pineda; L Feliubadaló; R Estévez; R de Cid; P Sanjurjo; A Zorzano; V Nunes; K Huoponen; A Reinikainen; O Simell; M L Savontaus; P Aula; M Palacín
Journal:  Nat Genet       Date:  1999-03       Impact factor: 38.330

5.  Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.

Authors:  J M Tanner; R H Whitehouse
Journal:  Arch Dis Child       Date:  1976-03       Impact factor: 3.791

Review 6.  Hormonal diagnosis of GH hypersecretory states.

Authors:  S Grottoli; V Gasco; F Ragazzoni; E Ghigo
Journal:  J Endocrinol Invest       Date:  2003       Impact factor: 4.256

7.  Growth hormone studies in lysinuric protein intolerance.

Authors:  I Goto; T Yoshimura; Y Kuroiwa
Journal:  Eur J Pediatr       Date:  1984-02       Impact factor: 3.183

8.  Hyperdibasicaminoaciduria, hyperammonemia, and growth retardation: Treatment with arginine, lysine, and citrulline.

Authors:  A E Awrich; W J Stackhouse; J E Cantrell; J H Patterson; D Rudman
Journal:  J Pediatr       Date:  1975-11       Impact factor: 4.406

9.  Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance.

Authors:  M P Sperandeo; M T Bassi; M Riboni; G Parenti; A Buoninconti; M Manzoni; B Incerti; M R Larocca; M Di Rocco; P Strisciuglio; I Dianzani; R Parini; M Candito; F Endo; A Ballabio; G Andria; G Sebastio; G Borsani
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

Review 10.  Lysinuric protein intolerance characterized by bone marrow abnormalities and severe clinical course.

Authors:  G Parenti; G Sebastio; P Strisciuglio; B Incerti; C Pecoraro; L Terracciano; G Andria
Journal:  J Pediatr       Date:  1995-02       Impact factor: 4.406

View more
  6 in total

1.  Growth hormone therapy is safe and effective in patients with lysinuric protein intolerance.

Authors:  Harri Niinikoski; Risto Lapatto; Matti Nuutinen; Laura Tanner; Olli Simell; Kirsti Näntö-Salonen
Journal:  JIMD Rep       Date:  2011-06-22

2.  A global Slc7a7 knockout mouse model demonstrates characteristic phenotypes of human lysinuric protein intolerance.

Authors:  Bridget M Stroup; Ronit Marom; Xiaohui Li; Chih-Wei Hsu; Cheng-Yen Chang; Luan D Truong; Brian Dawson; Ingo Grafe; Yuqing Chen; Ming-Ming Jiang; Denise Lanza; Jennie Rose Green; Qin Sun; J P Barrish; Safa Ani; Audrey E Christiansen; John R Seavitt; Mary E Dickinson; Farrah Kheradmand; Jason D Heaney; Brendan Lee; Lindsay C Burrage
Journal:  Hum Mol Genet       Date:  2020-08-03       Impact factor: 6.150

Review 3.  Overview of symptoms and treatment for lysinuric protein intolerance.

Authors:  Atsuko Noguchi; Tsutomu Takahashi
Journal:  J Hum Genet       Date:  2019-06-18       Impact factor: 3.172

4.  Growth Hormone Deficiency and Lysinuric Protein Intolerance: Case Report and Review of the Literature.

Authors:  Maines Evelina; Morandi Grazia; Olivieri Francesca; Camilot Marta; Cavarzere Paolo; Gaudino Rossella; Antoniazzi Franco; Bordugo Andrea
Journal:  JIMD Rep       Date:  2015-01-23

5.  Update on Lysinuric Protein Intolerance, a Multi-faceted Disease Retrospective cohort analysis from birth to adulthood.

Authors:  Wladimir Mauhin; Florence Habarou; Stéphanie Gobin; Aude Servais; Anaïs Brassier; Coraline Grisel; Célina Roda; Graziella Pinto; Despina Moshous; Fahd Ghalim; Pauline Krug; Nelly Deltour; Clément Pontoizeau; Sandrine Dubois; Murielle Assoun; Louise Galmiche; Jean-Paul Bonnefont; Chris Ottolenghi; Jacques de Blic; Jean-Baptiste Arnoux; Pascale de Lonlay
Journal:  Orphanet J Rare Dis       Date:  2017-01-05       Impact factor: 4.123

6.  Immune Dysregulation Mimicking Systemic Lupus Erythematosus in a Patient With Lysinuric Protein Intolerance: Case Report and Review of the Literature.

Authors:  Josefina Longeri Contreras; Mabel A Ladino; Katherine Aránguiz; Gonzalo P Mendez; Zeynep Coban-Akdemir; Bo Yuan; Richard A Gibbs; Lindsay C Burrage; James R Lupski; Ivan K Chinn; Tiphanie P Vogel; Jordan S Orange; M Cecilia Poli
Journal:  Front Pediatr       Date:  2021-05-20       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.